Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model

Figure 2

Abeta_3(pE)-42 determination in the SDS and FA extracts of APP-Ld brain. Pan-Abeta42 (a, b) and Abeta_3(pE)-42 (c,d) concentrations in SDS (a, c) and FA (b, d), as well as the corresponding Abeta_3(pE)-42 to pan-Abeta42 ratios (in %) (e, f).

(a)

(b)

(c)

(d)

(e)

(f)